Atlas Trials

Extension Study Evaluating Etanercept in Ankylosing Spondylitis

Clinical trial NCT00410046 · COMPLETED

Trial details

NCT number
NCT00410046
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2006-12-01
Primary completion
2008-10-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.